Home Tags Peripheral T-cell lymphoma

Tag: peripheral T-cell lymphoma

ASH 2018 Highlights Progress in Ongoing Development of Brentuximab Vedotin

As the premier hematology event in malignant and non-malignant hematology, the annual meeting of the American Society of Hematology (ASH), held this year from...

Supplemental Biologics License Application for Brentuximab Vedotin in Frontline Treatment of...

Seattle Genetics has submitted a supplemental Biologics License Application (BLA) for brentuximab vedotin (Adcetris®) to the U.S. Food and Drug Administration (FDA). The submission is...